LU75076A1 - - Google Patents

Info

Publication number
LU75076A1
LU75076A1 LU75076A LU75076A LU75076A1 LU 75076 A1 LU75076 A1 LU 75076A1 LU 75076 A LU75076 A LU 75076A LU 75076 A LU75076 A LU 75076A LU 75076 A1 LU75076 A1 LU 75076A1
Authority
LU
Luxembourg
Application number
LU75076A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU75076A1 publication Critical patent/LU75076A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J7/00—Adhesives in the form of films or foils
    • C09J7/10—Adhesives in the form of films or foils without carriers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LU75076A 1975-06-05 1976-06-03 LU75076A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2524955A DE2524955C3 (de) 1975-06-05 1975-06-05 Neue Thienyl-Prostaglandine und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
LU75076A1 true LU75076A1 (fr) 1977-03-07

Family

ID=5948288

Family Applications (1)

Application Number Title Priority Date Filing Date
LU75076A LU75076A1 (fr) 1975-06-05 1976-06-03

Country Status (20)

Country Link
US (1) US4258053A (fr)
JP (3) JPS527954A (fr)
AT (1) AT360671B (fr)
AU (1) AU517489B2 (fr)
BE (1) BE842687A (fr)
CA (1) CA1086722A (fr)
CH (1) CH625213A5 (fr)
DE (1) DE2524955C3 (fr)
DK (1) DK152675C (fr)
ES (1) ES448387A1 (fr)
FR (1) FR2313036A1 (fr)
GB (1) GB1553914A (fr)
HU (1) HU175238B (fr)
IE (1) IE43849B1 (fr)
IL (1) IL49716A (fr)
IT (1) IT1061525B (fr)
LU (1) LU75076A1 (fr)
MX (1) MX3609E (fr)
NL (1) NL188693C (fr)
SE (2) SE430158B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04107991U (ja) * 1991-02-26 1992-09-17 テーダブリユ電気株式会社 ヘツドホン
WO2016153094A1 (fr) * 2015-03-26 2016-09-29 비스메르 주식회사 Nouveau procédé de préparation d'un dérivé de 3-alcoxy-thiophène
CN106146455A (zh) * 2015-03-30 2016-11-23 维斯曼株式会社 3-烷氧基噻吩衍生物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956284A (en) * 1972-07-13 1976-05-11 Pfizer Inc. Heterocyclic 15-substituted-ω-pentanorprostoglandins
GB1428137A (en) * 1972-09-27 1976-03-17 Ici Ltd Prostanoic acid derivatives
GB1431561A (en) * 1973-01-31 1976-04-07 Ici Ltd Cyclopentane derivatives
US3931279A (en) * 1973-05-21 1976-01-06 The Upjohn Company 5-Oxa prostaglandin F2.sub.α analogs
US3932289A (en) * 1973-11-09 1976-01-13 Chevron Research Company Preparation of overbased carbonated sulfurized magnesium alkylphenates
GB1484591A (en) * 1974-04-11 1977-09-01 Ono Pharmaceutical Co Prostaglandin compositions

Also Published As

Publication number Publication date
DK248176A (da) 1976-12-06
IL49716A (en) 1980-10-26
IE43849L (en) 1976-12-05
ES448387A1 (es) 1977-08-01
JPS6261592B2 (fr) 1987-12-22
AT360671B (de) 1981-01-26
AU1460176A (en) 1977-12-08
IE43849B1 (en) 1981-06-17
IL49716A0 (en) 1976-08-31
IT1061525B (it) 1983-04-30
NL7605856A (nl) 1976-12-07
AU517489B2 (en) 1981-08-06
NL188693C (nl) 1992-09-01
DE2524955B2 (de) 1981-02-12
FR2313036A1 (fr) 1976-12-31
DK152675C (da) 1988-10-31
CA1086722A (fr) 1980-09-30
SE430158B (sv) 1983-10-24
JPS61243075A (ja) 1986-10-29
ATA413676A (de) 1980-06-15
SE7910057L (sv) 1979-12-06
CH625213A5 (fr) 1981-09-15
FR2313036B1 (fr) 1979-06-29
JPS6261593B2 (fr) 1987-12-22
MX3609E (es) 1981-03-31
US4258053A (en) 1981-03-24
JPS527954A (en) 1977-01-21
JPS6210233B2 (fr) 1987-03-05
DK152675B (da) 1988-04-11
DE2524955A1 (de) 1977-03-17
HU175238B (hu) 1980-06-28
JPS61246181A (ja) 1986-11-01
SE445112B (sv) 1986-06-02
DE2524955C3 (de) 1981-12-03
GB1553914A (en) 1979-10-10
SE7606318L (sv) 1976-12-06
BE842687A (fr) 1976-12-08

Similar Documents

Publication Publication Date Title
FR2313036B1 (fr)
JPS5432631B2 (fr)
JPS5249770U (fr)
JPS5435000Y2 (fr)
AU496568B2 (fr)
JPS5432574Y2 (fr)
JPS5430628Y2 (fr)
JPS527642U (fr)
JPS5287421U (fr)
CH593490A5 (fr)
CH587977A5 (fr)
CH599179A5 (fr)
CH599086A5 (fr)
CH599026A5 (fr)
CH598737A5 (fr)
CH596959A5 (fr)
CH601888A5 (fr)
CH596119A5 (fr)
CH595578A5 (fr)
CH595422A5 (fr)
CH605559A5 (fr)
CH605382A5 (fr)
CH595283A5 (fr)
CH594953A5 (fr)
CH600142A5 (fr)

Legal Events

Date Code Title Description
DT Application date
TA Annual fee